Neuroscientist Mortimer Mishkin Dies at 94

His work bridged the gap between psychology and neurobiology.

Written byLisa Winter
| 2 min read
Old man standing in front of a tree, smiling.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Renowned neuroscientist Mortimer Mishkin, best known for his work with cognitive and behavioral memory, died at his home in Bethesda, Maryland on October 2. He was 94.

Born December 13, 1926 in Massachusetts to Russian immigrants, Mishkin dropped out of high school to join the Navy during World War II. The Washington Post reports that the officer training program brought him to Dartmouth College, where he obtained a degree in business management in 1946. After his service, he was free to pursue his interest in psychology—a passion ignited by reading the works of Sigmund Freud in his youth, Mishkin explained in a 2001 interview. He attended McGill University in Montreal for his master’s degree in 1949, staying at the school for his PhD, which he received in 1951.

In 1955, Mishkin joined the National Institutes of Health (NIH), where he worked to understand the primate brain, bridging the gap between ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies